Company · CIK 0001880438 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
AN2 Therapeutics, Inc. · ANTX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 AForm 4 → | Sep 16, 5:35 pm EDT | Cameron C. Trenor IIIChief Medical Officer | 116,667 | — | — | 116,667 | — | |
| Sep 9, 2026 SForm 4 → | Sep 11, 7:45 pm EDT | Robin Shane ReadnourDirector | 1,108 | $6.02 | $6,675 | 624,765 | −0.18% | 10b5-1 |
| Sep 3, 2026 SForm 4 → | Sep 8, 7:42 pm EDT | Robin Shane ReadnourDirector | 16,119 | $6.04 | $97,323 | 625,350 | −2.51% | 10b5-1 |
| Sep 1, 2026 SForm 4 → | Sep 4, 4:25 pm EDT | Sarah Joanne WilliamsPrincipal Accounting Officer | 272 | $5.53 | $1,504 | 66,311 | −0.41% | late |
| Sep 1, 2026 PForm 4 → | Sep 2, 6:43 pm EDT | Margaret M FitzPatrickDirector | 2,098 | $5.53 | $11,602 | 10,708 | +24.4% | |
| Aug 17, 2026 SForm 4 → | Aug 19, 5:58 pm EDT | Robin Shane ReadnourDirector | 35,402 | $6.01 | $212,702 | 633,867 | −5.29% | 10b5-1 |
| Aug 14, 2026 GForm 4 → | Aug 14, 2:12 pm EDT | Joseph S ZakrzewskiDirector | 405,880 | — | — | 0 | — | |
| Jul 10, 2026 AForm 4 → | Jul 10, 7:41 pm EDT | Kabeer AzizDirector | 2,852 | — | — | 59,106 | — | |
| Jul 10, 2026 AForm 4 → | Jul 10, 7:41 pm EDT | Gilbert Lynn MarksDirector | 2,789 | — | — | 81,873 | — | |
| Jul 10, 2026 AForm 4 → | Jul 10, 7:40 pm EDT | Patricia A. MartinDirector | 766 | — | — | 18,863 | — | |
| Jul 8, 2026 SForm 4 → | Jul 10, 6:15 pm EDT | Joshua M EizenSee Remarks | 5,945 | $4.17 | $24,803 | 206,554 | −2.80% |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 AForm 4 → | Sep 16, 5:35 pm EDT | Cameron C. Trenor IIIChief Medical Officer | 233,333 | — | — | 233,333 | — |